IMPROVING LIVES THROUGH THE BETTER USE OF MEDICINES

Welcome to the Department of Clinical Pharmacy. Our faculty are pioneering new approaches to improving lives through better use of medicines with collaborative health services, precision pharmacotherapy, and translational research. We provide direct patient care through innovative, nationally recognized service models, and are advancing the profession with the next generation of educators and innovators through our PharmD Curriculum, Pharmacy Residency Programs, Clinical Pharmacy Translational Science PhD, and Clinical Pharmacy Translational Science Post-Doctoral Fellowship Program.

Learn more about our Ambulatory Care Enrichment (ACE) Program [register by 5/28/21]

Apply now for our Racial Equity to Advance Community Health (REACH) Clinical Pharmacy Fellowship

Faculty Spotlight

Bo Wen photo

Bernard Marini earned his Bachelor of Science in Anthropology-Zoology at the University of Michigan and his Doctor of Pharmacy from the University of Michigan College of Pharmacy. He completed his PGY1 Pharmacy Practice Residency and PGY2 Oncology Residency at the University of Michigan. Dr. Marini is Board Certified in Oncology Pharmacy and also serves as the residency program director for the PGY2 Oncology Residency program at the University of Michigan. He has been a Clinical Pharmacist Specialist in inpatient hematology since 2014 and recently joined the Department of Clinical Pharmacy as a Clinical Associate Professor in 2020.

Dr. Marini’s clinical practice primarily focuses on the care of patients with hematologic malignancies. His research focuses on improving clinical outcomes in hematology patients, oncology stewardship, and immunocompromised infectious diseases. He is passionate about expanding high-level hematology/oncology pharmacy research and is helping spearhead a multi-institutional hematology pharmacy research consortium. Dr. Marini also works with the neuro-oncology group to optimize the use and selection of precision medicine therapies. To this end, he helped create the CNS Targeted Agent Prediction (CNS TAP, http://www.cnstap.org/#/) tool, a decision-making algorithm for optimizing the selection of precision medicine therapies in patients with pediatric brain tumors. The CNS TAP tool is currently being utilized by the Pacific Pediatric Neuro-Oncology Consortium (PNOC) as a tumor board decision aid in their latest precision medicine trials. His research has been funded by a grant from the Hematology/Oncology Pharmacy Association (HOPA) and the Chad Carr Pediatric Brain Tumor Center. Dr. Marini is also passionate about pharmacy resident and student training and was awarded the PGY2 Oncology Pharmacy Preceptor of the Year Award in 2019.